Phoenix Molecular Designs
  • About US Mission & Vision Management Team Board of Directors Advisory Board
  • Science Precision Medicine Scientific Posters Publications
  • Pipeline
  • Media Events & Industry News
  • About Trial Details Patient Resources
  • Contact
Phoenix Molecular Designs
  • About/
    • About US
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Advisory Board
  • Our Science/
    • Science
    • Precision Medicine
    • Scientific Posters
    • Publications
  • Pipeline/
  • Investors & media/
    • Media
    • Events & Industry News
  • Phase 2 Clinical Trial/
    • About
    • Trial Details
    • Patient Resources
  • Contact/
tubes_red Watermarked.jpg
Phoenix Molecular Designs

Personalized and alternative cancer therapeutics for quality of life

Media

Phoenix Molecular Designs
  • About/
    • About US
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Advisory Board
  • Our Science/
    • Science
    • Precision Medicine
    • Scientific Posters
    • Publications
  • Pipeline/
  • Investors & media/
    • Media
    • Events & Industry News
  • Phase 2 Clinical Trial/
    • About
    • Trial Details
    • Patient Resources
  • Contact/
January 10, 2019

Phoenix Molecular Designs to start clinical trials to battle deadly form of breast cancer

January 10, 2019/ Guest User

Jan. 08
2019

SAN FRANCISCO, Jan. 08 2019 - Phoenix Molecular Designs CEO Dr. Sandra Dunn joined Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.

Watch the interview here

January 10, 2019/ Guest User/

Guest User

  • Phoenix Molecular Designs Announces ...
  • Phoenix Molecular Designs to ...
Contact us

2024© Phoenix Molecular Designs